Philippe Azam

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Christine Beeton, Heike Wulff, Nathan Standifer et al. · Proceedings of the National Academy of Sciences · 2006 · 538 citations

Life Sciences, Cell Biology, Immunology +17

Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam et al. · Molecular Pharmacology · 2005 · 224 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

Kazuyoshi Toyama, Heike Wulff, K. George Chandy et al. · Journal of Clinical Investigation · 2008 · 222 citations

Medicine, Cardiology, Pharmacology +17

Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice

Fádi Fakhouri, Elena Goicoechea de Jorge, Frédérique Brune et al. · Kidney International · 2010 · 108 citations

Medicine, Immunology, Nephrology +16

The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers

Philippe Azam, Jean-Luc Peiffer, Delphine Chamousset et al. · Toxicology and Applied Pharmacology · 2005 · 97 citations

Life Sciences, Dermatology, Immunology +12